However, this response differed across tumor types, with IL-12 resulting in largely CD4 migration in fibrosarcoma but pre-dominantly CD8 migration in ovarian cancer, and further work is required to determine its impact in glioblastoma [73]. Here, CD4 is linked to neoplasm.